Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer
A journal article entitled ‘Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer –
A Subgroup Analysis of the TOSCA Randomized Clinical Trial’ was published by Fausto Petrelli MD, Roberto Labianca MD and Alberto Zaniboni MD et al. on Jama Network on February 13. You can read their findings in their article.
Author:
Catie Young
Catie Young